Viral Immunotherapy: Interview with Dr. Moira Gunn at BioTech Nation


Welcome to a riveting episode of this BioTech Nation podcast, where we delve into the cutting-edge realm of cancer treatments with Dr. Paul Peter Tack, the visionary CEO of Candel Therapeutics. In this illuminating conversation, Dr. Tack unveils a ground-breaking approach to cancer therapy cantered around engineered viruses. Join us as we explore the intricacies of how these innovative viruses are strategically utilized to target solid tumours, deliver therapeutic genes, and orchestrate a formidable immune system response within the patient’s body. Get ready to embark on a journey through the fascinating intersection of virology and oncology, where science and technology converge to pave the way for a new era in the fight against cancer. This episode promises to be a compelling exploration of Candel Therapeutics’ revolutionary strides in the realm of cancer treatment.

Link to the podcast

BioTech Nation … with Dr. Moira Gunn | Engineering Viruses to Treat Solid Tumors… Dr. Paul Peter Tak, CEO of Candel Therapeutics

Paul Peter Tak

© Paul Peter Tak.
All rights reserved.